Article
In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.
Cancer immunology, immunotherapy : CII - 1 Jan 1992
Gonen B, Kahana O, Witz I P
Abstract excerpt
Cellular subclones of high and low tumorigenicity obtained from a mouse c-Ha-ras-transformed clone, were examined for their sensitivity to tumor-necrosis-factor (TNF)-mediated cytotoxicity. Cells of the highly tumorigenic subclones showed a significantly enhanced resistance to the cytotoxic effect of TNF plus cyclohexamide (CHI) as compared to cells of the low-tumorigenic subclones. The enhanced resistance to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
